March is designated as Myeloma Awareness Month, with various global activities that highlight and increase awareness of myeloma for research support and development. We would like to take this opportunity to extend our appreciation to all the researchers who have contributed to the fight against this disease. In particular, we would like to share some of the high-quality and innovative research findings in the field of myeloma, which were published in Cancers (ISSN: 2072-6694). We hope this announcement will provide useful information for this field. The list of relevant papers can be seen below.

“Poor Mobilizers in Lymphoma but Not Myeloma Patients Had Significantly Poorer Progression-Free Survival after Autologous Stem Cell Transplantation: Results of a Large Retrospective, Single-Center Observational Study”
by Normann Steiner, Georg Göbel, Leonie Mauser, Lena Mühlnikel, Marie Fischinger, Tina Künz, Wolfgang Willenbacher, Gabriele Hetzenauer, Jakob Rudzki, Walter Nussbaumer et al.
Cancers 2021, 13(3), 608; https://doi.org/10.3390/cancers15030608
Available online: https://www.mdpi.com/2072-6694/15/3/608

“Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice”
by Danai Dima, Fauzia Ullah, Sandra Mazzoni, Louis Williams, Beth Faiman, Austin Kurkowski, Chakra Chaulagain, Shahzad Raza, Christy Samaras, Jason Valent et al.
Cancers 2021, 13(7), 2160; https://doi.org/10.3390/cancers15072160
Available online: https://www.mdpi.com/2072-6694/15/7/2160

“Single-Stage versus Multi-Stage Intramedullary Nailing for Multiple Synchronous Long Bone Impending and Pathologic Fractures in Metastatic Bone Disease and Multiple Myeloma”
by Aditya V. Maheshwari, Andriy Kobryn, Juhayer S. Alam and Mikhail Tretiakov
Cancers 2021, 13(4), 1227; https://doi.org/10.3390/cancers15041227
Available online: https://www.mdpi.com/2072-6694/15/4/1227

“Metabolic Alterations in Multiple Myeloma: From Oncogenesis to Proteasome Inhibitor Resistance”
by Philip Weir, David Donaldson, Mary Frances McMullin and Lisa Crawford
Cancers 2021, 13(6), 1682; https://doi.org/10.3390/cancers15061682
Available online: https://www.mdpi.com/2072-6694/15/6/1682

“Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy”
by Shebli Atrash, Aytaj Mammadzadeh, Fulei Peng, Omar Alkharabsheh, Aimaz Afrough, Wei Cui, Zahra Mahmoudjafari, Al-Ola Abdallah and Hamza Hashmi
Cancers 2021, 13(11), 2891; https://doi.org/10.3390/cancers15112891
Available online: https://www.mdpi.com/2072-6694/15/11/2891

“Sialofucosylation Enables Platelet Binding to Myeloma Cells via P-Selectin and Suppresses NK Cell-Mediated Cytotoxicity”
by Alessandro Natoni, Marina Cerreto, Maria Stefania De Propris, Maria Teresa Petrucci, Francesca Fazio, Stefania Intoppa, Maria Laura Milani, Lucy Kirkham-McCarthy, Robert Henderson, Dawn Swan et al.
Cancers 2021, 13(7), 2154; https://doi.org/10.3390/cancers15072154
Available online: https://www.mdpi.com/2072-6694/15/7/2154

“New Strategies for the Treatment of Older Myeloma Patients”
by Alessandra Larocca, Lorenzo Cani, Giuseppe Bertuglia, Benedetto Bruno and Sara Bringhen
Cancers 2021, 13(10), 2693; https://doi.org/10.3390/cancers15102693
Available online: https://www.mdpi.com/2072-6694/15/10/2693

“Periplocin Overcomes Bortezomib Resistance by Suppressing the Growth and Down-Regulation of Cell Adhesion Molecules in Multiple Myeloma”
by Abdul Aziz, Haiqin Wang, Yanpeng Wang, Zhenzhen Li, Chaoying Yang, Zekang Ma, Xiaojuan Xiao and Jing Liu
Cancers 2021, 13(5), 1526; https://doi.org/10.3390/cancers15051526
Available online: https://www.mdpi.com/2072-6694/15/5/1526

“Efficacy and Safety of High-Dose Chemotherapy with Treosulfan and Melphalan in Multiple Myeloma”
by Cédric Gillich, Dilara Akhoundova, Michael Hayoz, Yolanda Aebi, Carlo R. Largiadèr, Katja Seipel, Michael Daskalakis, Ulrike Bacher  and Thomas Pabst
Cancers 2021, 13(10), 2699; https://doi.org/10.3390/cancers15102699
Available online: https://www.mdpi.com/2072-6694/15/10/2699

“Understanding DNA Damage Response and DNA Repair in Multiple Myeloma”
by Cole Petrilla, Joshua Galloway, Ruchi Kudalkar, Aya Ismael and Francesca Cottini
Cancers 2021, 13(16), 4155; https://doi.org/10.3390/cancers15164155
Available online: https://www.mdpi.com/2072-6694/15/16/4155

“The Real-World Evidence on the Fragility and Its Impact on the Choice of Treatment Regimen in Newly Diagnosed Patients with Multiple Myeloma over 75 Years of Age”
by Agata Tyczyńska, Marcela Krzysława Krzempek, Alexander Jorge Cortez, Artur Jurczyszyn, Katarzyna Godlewska, Hanna Ciepłuch, Edyta Subocz, Janusz Hałka, Anna Kulikowska de Nałęcz and Anna Wiśniewska
Cancers 2021, 13(13), 3469; https://doi.org/10.3390/cancers15133469
Available online: https://www.mdpi.com/2072-6694/15/13/3469

“Intramedullary Nailing with and without the Use of Bone Cement for Impending and Pathologic Fractures of the Humerus in Multiple Myeloma and Metastatic Disease”
by Andriy Kobryn, Patrick Nian, Joydeep Baidya, Tai L. Li and Aditya V. Maheshwari
Cancers 2021, 13(14), 3601; https://doi.org/10.3390/cancers15143601
Available online: https://www.mdpi.com/2072-6694/15/14/3601

You are welcome to submit relevant papers to the journal Cancers.

Cancers Editorial Office